BioScrip Investor Wants More Details On Option Care Merger
An investor hit home infusion care provider BioScrip Inc. with a proposed class action Friday in Delaware Chancery Court saying that company directors have not provided enough details about a merger...To view the full article, register now.
Already a subscriber? Click here to view full article